NAS10028,958S&P7,624−0.52%GOLD$4,008−1.29%BTC$80,528−0.33%VIX19.45+2.21%live tape · as of 08:04 UTC
The Screen · Technology · Scientific & Technical Instruments
Teledyne Technologies
TDY · a US exchange · USD · Market cap $28.7B · 15,800 employees
Teledyne Technologies Incorporated provides enabling technologies for industrial growth markets in the United States, Europe, Asia, and internationally.
Positioning political selling, disclosed 2026-09-25
Options put/call open interest 2.17, read 2026-10-24
Ethical passes the values gate
Price618.60 USD
Fair value728.22
Ethical score91.3/100
RatingFAIR VALUE
Our investment reviews on this name
2026-10-11Read Accumulation610.83+1.3% to today ✓Markdown gives way to Accumulation
2026-09-14Read Markdown595.23+3.9% to today Accumulation gives way to Markdown after a 13% slide in 4 weeks
2026-08-14Read Accumulation683.73-9.5% to today Distribution gives way to Accumulation after a 14% rise in 6 weeks
2026-07-02Read Distribution602.27+2.7% to today First review on file: Distribution with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Teledyne Technologies holds its Accumulation at $618.60. Consolidating, no directional conviction, held for 68 days.
As held on the ledger · 2026-10-16
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 68 days
Price at the screen
$618.60
Valuation
29.93 trailing · 23.09 forward price to earnings
Values screen
PASS· score 91.3
Beta
0.90
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
17.29%
Below 33%
Interest-bearing debt is just 17.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
8.80%
Below 49%
Money owed to the company is 8.8% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Teledyne Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-24. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TDY's ethical verdict changes
Today TDY passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · AFSC Investigate
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads FAIR VALUE: it trades at roughly a 18% discount to our $728.22 fair value, narrow competitive moat, 9.80% revenue growth.
Fair value range in USD, drawn from the 2026-10-16 screen. The gold marker is the market price at the same screen. A 17.7% margin of safety to the base estimate.
Third-party analyst targets: 12 covering, consensus Buy. The average target sits +23% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sensors Powering Industry Face a Steep Price
Picture the infrared cameras and digital sensors quietly enabling factory automation and medical imaging across continents. Teledyne delivers those enabling technologies with steady 8% revenue growth and a clean ethical screen, yet the shares sit at 24.4 times forward earnings while the opportunity rating flags them overvalued against a narrow moat and modest 9% return on equity.
That combination leaves little room for error. Profit margins of 15% look respectable, but the low return on capital and limited competitive edge suggest the business may struggle to compound value faster than the current price already assumes.
Analyst targets cluster near 750, yet history shows narrow-moat industrial suppliers often trade down when growth slows or cycles turn. The 12% gap to stated fair value does not change the overvalued verdict at these multiples.
TDY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-21Accumulation$618.60+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$618.60+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$618.60+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$618.60+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Accumulation$618.60-0.2%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$619.91+1.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Accumulation$613.66+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Accumulation$613.66+0.5%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729.
2026-10-02Markdown$610.83+2.6%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
